CT-LYA-301
Phase 3
LYA-Onco 1
Progression-free survival in second-line setting
Recruiting
Open trial detailClinical Trials & Evidence
Explore trial programs, evidence snapshots, and reprint pathways for compliant scientific exchange.
Trial status visibility
Endpoint summaries
Reprint request workflow
Trial Program Tracker
Therapy-linked studies and operational status.
CT-LYA-244
Phase 4
LYA-Immuno 2
Long-term persistence and safety
Active, not recruiting
Open trial detailCT-LYA-178
Phase 3
LYA-Neuro 3
Relapse reduction versus standard regimen
Primary completion met
Open trial detail